Oneview signs long-term contract with a second Victorian hospital

|

Published 18-JUN-2021 11:24 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Oneview Healthcare Plc (ASX:ONE) has signed a new 5-year contract with Northern Health in Melbourne’s fast-growing northern corridor, making it the company’s first Cloud Start customer in Australia.

Northern Health is a provider of public healthcare serving Melbourne’s northern region with five major public healthcare facilities.

Oneview’s Cloud Start product will be deployed to 126 beds in the recently completed $162.3 million Stage 2 Inpatient Unit Expansion Project which became operational on 3 May 2021.

This development is extremely important as it is Oneview’s first cloud win with the public sector in Australia (ONE has 3 hospitals live with NSW Health: Westmead Children’s, Randwick Children’s and Central Acute Services Building), as well as being the group’s first win of any kind with VicHealth.

It is also a positive indicator of demand for the group’s technology and services as it demonstrates that patient experience is a strategic priority for both the public and private sectors.

Cloud Start has tick of approval from Samsung

Oneview’s products include Cloud Start and Cloud Enterprise with the former not requiring integration into the Electronic Health Record, making it easier and faster to deploy.

Importantly, this is the product Samsung is selling in Oneview’s bundled SKU (Stock Keeping Units) in the US.

Hospitals can increase their patient satisfaction scores through technology solutions built by Samsung and its partners.

Samsung is now providing single SKU-bundled solutions for patient engagement that include a secure mobile device and partner software applications.

These bundles enable hospitals and healthcare providers to improve patient usability and functionality while reducing the need for multiple generic devices.

In addition, hospitals can own a fully integrated SKU solution that may be easily deployed within the hospital system.

The system will go live in July and with relatively quick revenue recognition it will be one of the key value drivers of the Cloud product.

Highlighting the importance of this development and the advantages offered by Cloud CXP, Eleni Tzaros, ANZ Sales Director for Oneview said, “We are delighted to welcome Northern Health to our global health service partnerships.

"The Cloud CXP offering has provided Northern Health with the opportunity to catalyse their innovation strategy with the solution due to go live next month.

"This speaks to the importance of Cloud offerings for agility, speed to market and value-based outcomes.”

For more information read: ONE signs ANOTHER deal - the second in 8 days



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X